0
Signin
countryflagUS

18889881171

AAPL 183.36 5.9701% MSFT 406.8 2.2522% GOOG 169.01 0.3265% GOOGL 167.21 0.3541% AMZN 186.235 0.8202% NVDA 887.83 3.4562% META 452.05 2.3479% TSLA 181.14 0.6277% TSM 141.56 3.9125% LLY 734.97 -2.7702% V 268.47 0.3214% AVGO 1278.11 3.1924% JPM 190.51 -0.6% UNH 492.45 -0.1055% NVO 123.05 -0.7821% WMT 59.82 0.1842% LVMUY 168.5 2.1584% XOM 116.02 -0.1893% LVMHF 841.0 1.8789% MA 443.58 0.5622%

Minerva Surgical Inc

Healthcare US UTRS

0.001USD
-(-%)

Last update at 2024-05-02T17:19:00Z

Day Range

0.0010.001
LowHigh

52 Week Range

1.3710.64
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -34.10100M -21.45500M -18.39500M -52.04600M
Minority interest - - - -
Net income -34.11200M -21.46400M -18.26300M -69.79600M
Selling general administrative 14.37M 22.18M 8.21M 8.38M
Selling and marketing expenses 38.33M 32.19M 22.97M 22.12M
Gross profit 27.24M 30.52M 19.12M 11.80M
Reconciled depreciation 10.81M 10.62M 7.08M 1.68M
Ebit -30.89900M -29.14500M -15.39000M -19.63700M
Ebitda -30.87900M -18.85500M -8.16200M -17.65600M
Depreciation and amortization 0.02M 10.29M 7.23M 1.98M
Non operating income net other - -21.28500M - -
Operating income -30.89900M -29.14500M -15.39000M -19.63700M
Other operating expenses 81.19M 81.25M 53.16M 45.65M
Interest expense 3.22M 11.73M 12.14M 17.58M
Tax provision 0.01M 0.00900M -0.13200M 0.00000M
Interest income 0.09M 0.01000M 0.08M 0.14M
Net interest income -3.13300M -11.71800M -12.05900M -17.44400M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.01M 0.00900M -0.13200M 17.75M
Total revenue 50.29M 52.10M 37.77M 26.01M
Total operating expenses 58.14M 59.67M 34.51M 31.44M
Cost of revenue 23.05M 21.58M 18.65M 14.21M
Total other income expense net -3.20200M 7.69M -3.00500M -32.40900M
Discontinued operations - - - -
Net income from continuing ops -34.11200M -21.46400M -18.26300M -52.04600M
Net income applicable to common shares -34.11200M -21.46400M -18.26300M -52.04600M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 68.90M 115.09M 92.05M 46.68M
Intangible assets 26.78M 34.97M 43.14M -
Earning assets - - - -
Other current assets 4.48M 4.14M 0.36M 0.28M
Total liab 51.72M 70.99M 313.86M 251.21M
Total stockholder equity 17.18M 44.10M -221.81100M -204.52400M
Deferred long term liab - - - -
Other current liab 8.89M 18.60M 27.87M 10.98M
Common stock 0.03M 0.03M 0.00100M 0.00100M
Capital stock 0.03M 0.03M 0.00100M 0.00100M
Retained earnings -283.66800M -249.55600M -228.09200M -209.82900M
Other liab - 9.09M 61.67M 39.50M
Good will - - - -
Other assets 0.69M 0.52M 0.60M 0.60M
Cash 6.94M 40.61M 17.36M 27.09M
Cash and equivalents - - - -
Total current liabilities 14.28M 22.62M 33.27M 15.22M
Current deferred revenue 0.34M 0.21M 0.22M 0.05M
Net debt 32.75M -1.33400M 79.93M 48.81M
Short term debt 2.25M 0.19M 1.67M -
Short long term debt 1.89M 0.19M 1.67M -
Short long term debt total 39.69M 39.27M 97.29M 75.89M
Other stockholder equity 300.81M 178.53M 6.27M 5.29M
Property plant equipment 5.31M 4.59M 2.88M 2.27M
Total current assets 36.12M 75.00M 45.42M 43.81M
Long term investments - - - -
Net tangible assets -9.59700M 9.13M -264.95200M -204.52400M
Short term investments - - - -
Net receivables 7.24M 7.29M 8.38M 3.95M
Long term debt 37.44M 39.27M 95.62M 75.89M
Inventory 16.85M 15.68M 10.20M 4.74M
Accounts payable 2.80M 3.63M 3.51M 4.19M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income 0.01M 0.01M 0.01M 0.01M
Additional paid in capital - - - -
Common stock total equity - 0.03M - -
Preferred stock total equity - - - -
Retained earnings total equity - -249.55600M - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 0.69M 0.52M 0.60M 0.60M
Deferred long term asset charges - - - -
Non current assets total 32.78M 40.09M 46.62M 2.87M
Capital lease obligations 0.35M - - -
Long term debt total - 39.09M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.07300M -25.58400M -15.45300M -0.22300M
Change to liabilities 0.00000M 3.30M -0.68700M -2.98400M
Total cashflows from investing activities - -25.58400M -15.45300M -0.22300M
Net borrowings - 4.16M 17.96M 43.81M
Total cash from financing activities -4.96400M 71.21M 18.08M 43.16M
Change to operating activities - -3.86400M 0.99M 0.37M
Net income -34.11200M -21.46400M -18.26300M -52.04600M
Change in cash -40.60400M 23.25M -9.61700M 23.14M
Begin period cash flow 48.41M 25.17M 34.78M 11.64M
End period cash flow 7.81M 48.41M 25.17M 34.78M
Total cash from operating activities -35.56700M -22.37900M -12.24100M -19.79200M
Issuance of capital stock 0.04M 70.72M 0.12M 0.11M
Depreciation 10.81M 10.62M 7.08M 1.68M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory -4.13500M -9.07200M 1.26M 0.83M
Change to account receivables 0.05M 1.09M -4.43200M -0.33200M
Sale purchase of stock - 70.72M - -
Other cashflows from financing activities -5.00000M 35.86M 17.96M 52.10M
Change to netincome - -6.33400M -1.51000M 18.64M
Capital expenditures 0.07M 0.58M 0.45M 0.22M
Change receivables - 1.09M - -
Cash flows other operating - -39.89800M - -
Exchange rate changes - - - -
Cash and cash equivalents changes - 23.25M - -
Change in working capital -11.05300M -8.54900M -2.86500M -2.11300M
Stock based compensation 6.98M 6.82M 0.86M 0.59M
Other non cash items -8.18600M 9.62M 1.08M 17.16M
Free cash flow -35.64000M -22.96300M -12.69400M -20.01500M

Fundamentals

  • Previous Close 0.001
  • Market Cap15.09M
  • Volume26100
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-25.56000M
  • Revenue TTM51.69M
  • Revenue Per Share TTM8.31
  • Gross Profit TTM 27.24M
  • Diluted EPS TTM-6.85

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
UTRS
Minerva Surgical Inc		 - -% 0.001 - - 0.25 0.64 0.88 -2.2352
ABT
Abbott Laboratories		 -0.02 0.02% 105.90 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 1.82 0.56% 328.45 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.77 0.95% 81.69 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.83 1.15% 72.86 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Minerva Surgical Inc

4255 Burton Drive, Santa Clara, CA, United States, 95054

Key Executives

Name Title Year Born
Mr. David M. Clapper Pres, CEO & Director 1952
Mr. Joel R. Jung MBA Chief Financial Officer 1958
Mr. Dominique J. Filloux Chief Operating Officer 1963
Mr. Thomas Pendlebury VP of Sales & Marketing NA
Ms. Wendy Bowman VP of HR NA
Ms. Joanne Long VP of Corp. Controller NA
Dr. Evgueni V. Skalnyi M.D. VP of Medical Affairs 1966

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).